阿里健康(00241.HK)與慧醫天下達成「互聯網+」戰略合作
阿里健康(00241.HK)與慧醫天下互聯網醫療平台達成戰略合作,雙方將發揮各自在互聯網醫療領域的優勢,並攜手眾安保險(06060.HK),共同打造專注服務糖尿病患者的「互聯網+」慢病保險產品「安唐保」,共創可長效延展的院外管理新模式。
作為一款專為糖尿病患者打造的產品,「安唐保」將整合資源,為患者提供全週期、全方位健康服務,覆蓋專業醫生的在線問診、開方用藥,專業平台的科普患教、控糖管理,以及專業保險的理賠報銷等環節。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.